Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007636 |
---|---|
Receipt number | R000009008 |
Scientific Title | Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed |
Date of disclosure of the study information | 2012/04/01 |
Last modified on | 2022/09/18 17:39:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/04/01 17:30:17 | ||
2 | Update | 2014/04/01 19:48:49 | Email Last name of contact person Last name of contact person |
|
3 | Update | 2015/04/15 21:40:27 | Recruitment status |
|
4 | Update | 2022/09/18 17:29:38 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
5 | Update | 2022/09/18 17:34:46 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
6 | Update | 2022/09/18 17:37:30 | Recruitment status Date of IRB |
|
7 | Update | 2022/09/18 17:39:14 | Date of the first journal publication of results |